# Effect of Adjunctive Metformin on Recurrence of Non-DM Colorectal Cancer Stage II High-risk/ III Colorectal Cancer

> **NCT02614339** · PHASE3 · UNKNOWN · sponsor: **Yonsei University** · enrollment: 593 (estimated)

## Conditions studied

- Non-DM Stage II High-risk Colorectal Cancer
- Non-DM Stage III Colorectal Cancer

## Interventions

- **DRUG:** metformin
- **DRUG:** control

## Key facts

- **NCT ID:** NCT02614339
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2021-07
- **Final completion:** 2021-07
- **Target enrollment:** 593 (ESTIMATED)
- **Last updated:** 2019-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02614339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02614339, "Effect of Adjunctive Metformin on Recurrence of Non-DM Colorectal Cancer Stage II High-risk/ III Colorectal Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02614339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*